Stockreport

BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

BioAtla, Inc.  (BCAB) 
PDF SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Ac [Read more]